With the post of EU chief science adviser axed, Research Commissioner Carlos Moedas is to look at new ways of providing independent scientific inputs to policymaking. A list of the options will be presented before the summer, he tells Science|Business
While other social media networks for researchers are about showing off publications or keeping tabs on impact metrics, Piirus makes introductions. This is the way to find your perfect partner – for research, says Piirus founder Fiona Colligan
CERN is getting ready to switch on its massive underground collider again. The Higgs boson, the standout discovery of the last few years, is in the bag, so what are physicists looking for now?
The MED-EU strategic project aims to raise EU funds for scientific research and innovation. The project is coordinated by the University of Bologna and a few clinical institutes such as the S.Orsola-Malpighi University Hospital, the Rizzoli Institute for Orthopedics and the Institute for Neurologic Sciences of the Bellaria hospital.
Breakthroughs in renewable energy don’t come from Eureka moments in the laboratory, but from long term effort and investment to push nascent technologies to the point of cost efficiency, says Carlos Härtel, GE’s head of R&D in Europe
Fluidic Analytics Limited, a spinout from the University of Cambridge, has raised £1.56 million (US$2.4 million) in a Series A financing led by Cambridge Enterprise and including DFJ Esprit, IQ Capital, Parkwalk Advisors and Amadeus Capital Partners as co-investors.
A total of 277 SMEs will get funding to help get promising commercial ideas up and running. Companies from Spain, Italy, the UK, the Netherlands and France did well, but the success rate is low overall
The Bloodhound car will be a 1,000mph machine that is part spaceship, part jet fighter and part racing car. This is not a big vanity project but an engineering adventure designed to stir a new generation, says Mark Elvin
As the EU lays out some of its hoped-for outcomes from controversial EU-US trade talks in pharma, medical devices, energy and other fields, the European Ombudsman insists more transparency is needed
Allowing academics to move their pensions from country-to-country when taking up jobs at institutions across the EU has broad support. But there is a swathe of technical and legal detail to sort out and universities need to sign up
A new drug for ovarian cancer, developed by researchers at the University of Cambridge and AstraZeneca, has become the first of new class of drugs, known as PARP-inhibitors, to be granted approval anywhere in the world. The drug, Lynparza, has been granted Marketing Authorisation from the European Commission.
A total of 22 new companies were founded in 2014 by researchers from ETH Zurich. These spin-offs are among the most successful in Switzerland. One of the year's highlights was Covagen, which was acquired for over CHF 200 million. The latest figures also reveal that the university is on the right track with its promotion programmes.
To stay competitive in the global race to develop advanced manufacturing technologies, German industry must define and develop the digital framework for the “Internet of Things,” enabling everything from driverless cars to smart cities and e-health, a top official tells Science|Business
Portugal-based Gulbenkian Foundation will join an established research team, active in 11 African countries, to help fight rampant diseases like malaria and AIDS
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.